SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Becklund Irene

(Last)

(First)

(Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO

94123

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/15/2021

3. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Interim PFO/PAO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock	16,183	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (right to buy)	⁽¹⁾	07/09/2029	Class A Common Stock	27,178	$1.75	D
Stock Option (right to buy)	⁽²⁾	12/23/2030	Class A Common Stock	22,648	$9.41	D
Restricted Stock Unit	⁽³⁾	⁽³⁾	Class A Common Stock	67,947	$0.00	D
Restricted Stock Unit	⁽⁴⁾	⁽⁴⁾	Class A Common Stock	2,564	$0.00	D
Restricted Stock Unit	⁽⁵⁾	⁽⁵⁾	Class A Common Stock	2,215	$0.00	D
Restricted Stock Unit	⁽⁵⁾	⁽⁵⁾	Class A Common Stock	6,646	$0.00	D
Restricted Stock Unit	⁽⁴⁾	⁽⁴⁾	Class A Common Stock	51	$0.00	D
Restricted Stock Unit	⁽⁵⁾	⁽⁵⁾	Class A Common Stock	44	$0.00	D
Restricted Stock Unit	⁽⁵⁾	⁽⁵⁾	Class A Common Stock	132	$0.00	D
Restricted Stock Unit	⁽⁵⁾	⁽⁵⁾	Class A Common Stock	43,002	$0.00	D

Explanation of Responses:

1. 25% of the shares of Class A common stock subject to the Stock Option vested on June 3, 2021 and the remaining 75% vest in a series of thirty-six successive equal monthly installments thereafter, subject to the Reporting Person's continuous service with the issuer.

2. The shares of Class A common stock vest in a series of forty-eight successive equal monthly installments beginning on February 16, 2021, subject to the Reporting Person's continuous service with the issuer.

3. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs vest over a four-year period, with 6.25% of the RSUs vesting on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring on or after June 15, 2021, subject to the Reporting Person's continuous service with the issuer.

4. The RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs vest over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date occurring on or following the one-year anniversary of June 15, 2020 and the remaining 75% vest in equal quarterly installments over the following three years, on each Company Quarterly Vesting Date, subject to the Reporting Person's continuous service with the issuer.

5. The RSUs represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs vest over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after June 15, 2021, subject to the Reporting Person's continuous service with the issuer.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Alexandra Cotter Wilkins, Attorney-in-Fact	11/18/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.